Urologic Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.
Urologic Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland; Division of Urology, University of Cincinnati College of Medicine, Cincinnati, Ohio.
J Urol. 2018 Apr;199(4):976-982. doi: 10.1016/j.juro.2017.10.048. Epub 2018 Jan 20.
We sought to determine whether saturation of the index lesion during magnetic resonance imaging-transrectal ultrasound fusion guided biopsy would decrease the rate of pathological upgrading from biopsy to radical prostatectomy.
We analyzed a prospectively maintained, single institution database for patients who underwent fusion and systematic biopsy followed by radical prostatectomy in 2010 to 2016. Index lesion was defined as the lesion with largest diameter on T2-weighted magnetic resonance imaging. In patients with a saturated index lesion transrectal fusion biopsy targets were obtained at 6 mm intervals along the long axis of the index lesion. In patients with a nonsaturated index lesion only 1 target was obtained from the lesion. Gleason 6, 7 and 8-10 were defined as low, intermediate and high risk, respectively.
Included in the study were 208 consecutive patients, including 86 with a saturated and 122 with a nonsaturated lesion. Median patient age was 62.0 years (IQR 10.0) and median prostate specific antigen was 7.1 ng/ml (IQR 8.0). The median number of biopsy cores per index lesion was higher in the saturated lesion group (4 vs 2, p <0.001). The risk category upgrade rate from systematic only, fusion only, and combined fusion and systematic biopsy results to prostatectomy was 40.9%, 23.6% and 13.8%, respectively. The risk category upgrade from combined fusion and systematic biopsy results was lower in the saturated than in the nonsaturated lesion group (7% vs 18%, p = 0.021). There was no difference in the upgrade rate based on systematic biopsy between the 2 groups. However, fusion biopsy results were significantly less upgraded in the saturated lesion group (Gleason upgrade 20.9% vs 36.9%, p = 0.014 and risk category upgrade 14% vs 30.3%, p = 0.006).
Our results demonstrate that saturation of the index lesion significantly decreases the risk of upgrading on radical prostatectomy by minimizing the impact of tumor heterogeneity.
我们旨在确定磁共振成像-经直肠超声融合引导活检时指数病变的饱和度是否会降低从活检到根治性前列腺切除术的病理升级率。
我们分析了 2010 年至 2016 年间在一家机构进行融合和系统活检后接受根治性前列腺切除术的前瞻性维护的单机构数据库。指数病变定义为 T2 加权磁共振成像上最大直径的病变。在指数病变饱和度的患者中,经直肠融合活检的靶标是沿着指数病变的长轴每隔 6 毫米获得一次。在指数病变非饱和度的患者中,仅从病变中获得 1 个靶标。Gleason 6、7 和 8-10 分别定义为低、中、高危。
研究纳入了 208 例连续患者,包括 86 例饱和度和 122 例非饱和度病变。中位患者年龄为 62.0 岁(IQR 10.0),中位前列腺特异性抗原为 7.1ng/ml(IQR 8.0)。在饱和度病变组中,每例指数病变的活检核心中位数更高(4 对 2,p <0.001)。从系统仅、融合仅和融合与系统联合活检结果到前列腺切除术的风险类别升级率分别为 40.9%、23.6%和 13.8%。在饱和度病变组中,从联合融合和系统活检结果的风险类别升级率低于非饱和度病变组(7%对 18%,p = 0.021)。在两组中,基于系统活检的升级率没有差异。然而,在饱和度病变组中,融合活检结果的升级显著减少(Gleason 升级 20.9%对 36.9%,p = 0.014 和风险类别升级 14%对 30.3%,p = 0.006)。
我们的结果表明,指数病变的饱和度通过最大限度地减少肿瘤异质性的影响,显著降低了根治性前列腺切除术后升级的风险。